oxybutynin has been researched along with Behcet Syndrome in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciancio, G | 1 |
| Colina, M | 1 |
| La Corte, R | 1 |
| Lo Monaco, A | 1 |
| De Leonardis, F | 1 |
| Trotta, F | 1 |
| Govoni, M | 1 |
1 trial available for oxybutynin and Behcet Syndrome
| Article | Year |
|---|---|
Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: a case series.
Topics: Adult; Behcet Syndrome; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; R | 2010 |